Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001842190-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 9, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
13,953
Total Value
$1,220,885.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 4, 2026 | Sale | 5,387 | $85.00 | $457,895.00 | 7,933 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 4, 2026 | Sale | 5,386 | $90.00 | $484,740.00 | 2,547 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 4, 2026 | Sale | 1,590 | $85.00 | $135,150.00 | 3,180 | Indirect | By Spouse's Roth IRA | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 4, 2026 | Sale | 1,590 | $90.00 | $143,100.00 | 1,590 | Indirect | By Spouse's Roth IRA | View Details |